pharmaphorum

OCTOBER 25, 2022

Healthware, as the key R&D partner, has been supporting Orion Corporation to design and develop a novel treatment, a Digital Therapeutics software solution “ Rohkea ” to treat Chronic Pain ( DTxP ) using Virtual Reality ( VR ). The attendance is free but requires registration here.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Medicine 98

Worldwide Clinical Trials

MAY 20, 2022

Since these therapies go beyond symptom management to address the cause of the disease, the treatment potential surpasses what most previous treatments could offer to patients. Many programs have had safety concerns resulting in clinical holds that halt or end their program. But no strategy is perfect.

Gene Therapy 130

Gene Therapy Gene Development Research 130

pharmaphorum

JUNE 22, 2022

Pfizer has harnessed the expertise of health data specialist Truveta to provide close monitoring of safety and other signals for its products, including COVID-19 vaccine Comirnaty, almost in real-time. “We hope to continue to find additional benefit from this growing data such as identifying and addressing health disparities.”

Vaccination 105

Vaccination Vaccine Pharma Companies Medicine 105

pharmaphorum

SEPTEMBER 19, 2021

Any lingering hope that Pfizer’s may finally get a regulatory approval for its nerve growth factor (NGF) inhibitor tanezumab looks to have been dashed after the EMA’s human medicines committee rejected the drug.

Drugs 117

Drugs Clinical Trials Clinical Trials Medicine 117

pharmaphorum

SEPTEMBER 21, 2022

The European Commission has followed the lead of the US FDA and approved AstraZeneca’s Tezspire as an add-on maintenance therapy for patients with severe asthma, becoming the first and only biologic that can be used in all patients, and not restricted to those with specific forms of the disease. billion or more.

Sales 111

Sales Medicine Clinical Trials Clinical Trials 111

XTalks

FEBRUARY 22, 2024

This initiative positions the Center as a trailblazer in the US, showcasing a deep commitment to leveraging AI to bolster patient care, with a keen focus on safety, equity and excellence. AI’s capabilities, from machine learning to robotics, are transforming disease diagnosis, patient care and operational efficiency.

Development 59

Development Medicine Production Drugs 59

XTalks

JANUARY 5, 2024

Eli Lilly launched LillyDirect this week, an online service that provides access to the company’s medicines, including its newly approved weight loss drug Zepbound (tirzepatide). It will also help patients access Lilly’s savings programs, specifically the company’s savings cards, designed to reduce out-of-pocket costs for patients.

Drugs 59

Drugs Pharmacy Cosmetics Insulin 59

Fossil Remedies

JULY 15, 2022

As the number of people affected by these problems is increasing, there is a high demand for medicines required to treat them. Choose a company that offers the best quality cardiac and diabetic medicines. A renowned company offers PCD pharma franchise opportunities in diabetic and cardiac medicines.

Pharma Companies 52

Pharma Companies Packaging Packaging Medicine 52

Drug Discovery World

FEBRUARY 13, 2024

It has demonstrated efficacy in in vitro and in vivo models of fibrosis, as well as favourable safety and pharmacokinetic profiles in Phase I clinical studies. We look forward to commercialising our product with a pharma partner to bring better treatment options to patients with fibrosis.”

Drugs 52

Drugs In-Vivo In-Vitro Medicine 52

pharmaphorum

FEBRUARY 10, 2021

The project is coordinated by the University of Bologna and funded by the European Union’s Horizon 2020 research and innovation programme that involves more than a dozen partner institutions, including Italian startup InSilicoTrials. Two other companies, a spin-off from the University of Catania called Mimesis and RS Print, are also involved.

Development 76

Development Drugs Medicine Life Science 76

Cloudbyz

MARCH 6, 2024

In this blog post, we delve into the rise of biologics and explore how they are reshaping the pharmaceutical industry and improving patient outcomes. Longer Lasting Effects: Many biologics have prolonged therapeutic effects, allowing for less frequent dosing regimens and improved patient compliance.

Gene 73

Gene Immune Response Manufacturing Gene Therapy 73

XTalks

FEBRUARY 3, 2023

Orserdu (elacestrant) is the first endocrine innovation in 20 years specifically targeting ESR1 mutations in ER+, HER2- advanced or metastatic breast cancer patients with disease progression following at least one line of endocrine therapy. . Mutations in the ESR1 , however, have contributed to the rise of endocrine resistance.

Clinical Trials 97

Clinical Trials Clinical Trials FDA Approval Trials 97

Pharmaceutical Technology

FEBRUARY 3, 2023

Once a patient is infected with HIV, they are infected for life, except for a few rare cases, he says. While the production of bNAbs is a complicated process, vaccines could be designed to prompt the body to induce bNAbs, says Karim. The failure of several late-stage trials highlights the challenging nature of HIV vaccine development.

Vaccination 293

Vaccination Vaccine Antibody Trials 293

Drug Discovery World

JANUARY 10, 2024

Emphasising that 34,000 patients worldwide have received commercially available CAR-T cell immunotherapies, the commentary notes that the observed rate of 20 reported cases of T cell malignancies is notably lower than that reported for more conventional alternative treatments.

Gene Therapy 59

Gene Therapy Genotoxicity Gene Genetics 59

pharmaphorum

JANUARY 31, 2022

They can not only reduce direct hospital costs but also improve patients’ quality of life, ability to function, and productivity. Pfizer’s Josh Raysman, Saad Saeed, and Shanaya Deboo discuss vaccine awareness, access, and innovation. Vaccines are essential for public health on a global scale. The importance of innovation.

Vaccination 97

Vaccination Vaccine Development Marketing 97

Drug Discovery World

MAY 1, 2024

The company also partnered with a top 20 pharma company and has been successful in identifying antibody candidates for a target of interest, with greater diversity (2.3x) and accuracy compared to alternative bioinformatics pipeline selection methods. million, comprising new investment and match funding from the UKI2S Innovate Accelerator.

Antibody 59

Antibody FDA Approval Drugs Development 59

pharmaphorum

NOVEMBER 23, 2022

I’ve always worked as a consultant for pricing and access strategies for clients, helping them to get drugs to market and access patients. I haven’t presented; I’m here mainly as the business team for some of our professional clients, but also partners as part of that topic, also. Innovative offerings around market access.

Life Science 98

Life Science Marketing Medicine Production 98

Drug Discovery World

SEPTEMBER 29, 2023

Seven companies have been highlighted in Clarivate’s ‘Companies to Watch Report’ for delivering more effective and safer medicines to market faster by leveraging artificial intelligence (AI) and machine learning (ML) technology. Enveda Biosciences – focuses on the natural world for drug discovery.

Drugs 52

Drugs Medicine Development Production 52

pharmaphorum

SEPTEMBER 20, 2022

Aurinia Pharma and partner Otsuka have secured approval in the EU for Lupkynis, billed as the first oral treatment for active nephritis in patients with the autoimmune disease systemic lupus erythematosus. Meanwhile, Lupkynis has also been filed with the Swiss Agency for Therapeutic Products and is currently under review.

Drugs 52

Drugs Production Marketing Licensing 52

Pfizer

JANUARY 27, 2023

The Carter Center has been a proud partner in the trachoma elimination journey, which is core to our commitment to expanding simple health interventions that have a life-changing impact.” Everyone, no matter where they live, should have access to life-saving medicines.

Bacteria 75

Bacteria Medicine Containment Manufacturing 75

The Pharma Data

APRIL 4, 2022

Chief Medical Officer and Head of Global Product Development, Roche. More than one million people with severe or critical COVID-19 have already been treated with Actemra/RoActemra worldwide, demonstrating the important role of this medicine in the fight against the pandemic.”. If approved, Actemra/RoActemra would be the first U.S.

FDA Approval 52

FDA Approval Clinical Trials Clinical Trials In-Vitro 52

pharmaphorum

SEPTEMBER 20, 2022

The phase 1/3 ROSALIA study showed that the copycat denosumab matched Amgen’s brand on multiple pharmacokinetics, pharmacodynamics, efficacy, safety, and immunogenicity measures in postmenopausal women with osteoporosis, said Sandoz in a statement. billion TNF inhibitor Enbrel (etanercept) and $2.25

Branding 52

Branding Medicine Marketing Sales 52

pharmaphorum

DECEMBER 15, 2020

While the world has had to come together to fight COVID-19, so too has the pharmaceutical industry in ensuring that essential medicines reach patients in need. Surges in demand have created challenges throughout the supply chain, from production line capacity to managing the shipment of products from one country to another.

Medicine 93

Medicine Production Manufacturing Life Science 93

Drug Discovery World

JANUARY 23, 2023

He said: “In addition to the great showcase of exciting new technology, the programming of the event has identified trending platform opportunities such as the panel on decentralising advanced therapies.” Dave Yoder is Senior Manager, Product Strategy at Aldevron.

Gene Therapy 98

Gene Therapy Gene Manufacturing Production 98

Drug Discovery World

MARCH 29, 2023

aureus in patients undergoing open heart surgery by 2.5 of XF-73 nasal gel treated patients were completely decolonised of nasal S. aureus in patients undergoing open heart surgery by 2.5 of XF-73 nasal gel treated patients were completely decolonised of nasal S. reduction in S.

Clinical Trials 52

Clinical Trials Clinical Trials Production Clinical Development 52

The Pharma Data

JUNE 14, 2023

Overexpression or genetic activation of Cyclin Dependent Kinase 2 (CDK2) binding partner cyclin E is a key oncogenic process in several cancers. “We look forward to progressing Cedilla’s programs and continuing to focus on assets that allow better patient selection. Financial details have not been disclosed.

Licensing 40

Licensing Licensing Life Science Development 40

The Pharma Data

JUNE 28, 2023

The study cohort includes 128 adult patients with relapsed or refractory (R/R) FL who received at least two or more lines of systemic therapy. percent of patients were double refractory to an anti-CD20 monoclonal antibody and an alkylating agent. vice president, therapeutic area head for hematology, AbbVie. percent (1.6

Trials 40

Trials Antibody Clinical Trials Clinical Trials 40

Drug Discovery World

JUNE 1, 2023

Antibody-drug conjugates (ADCs) are biopharmaceutical products in which a monoclonal antibody (mAB) is linked to a small molecule drug with a stable linker 1. According to NCBI, most of the ADCs developed so far are for use in the treatment of cancer, but there is plenty of potential for using ADCs to treat other diseases 1.

Antibody 98

Antibody Marketing Drugs Licensing 98

pharmaphorum

JANUARY 25, 2022

Already, this process is being accelerated by the impact of COVID-19 – as broader digital solutions became necessary in the treatment of patients globally. And these solutions can provide patients with continuous support and therapy when they are actively experiencing symptoms or are unable to immediately access their healthcare providers.”.

Medicine 111

Medicine In-Vivo In-Vitro Development 111

The Pharma Data

JUNE 7, 2023

If approved in this patient population, dostarlimab plus chemotherapy could represent the first meaningful frontline treatment advancement in decades for patients with primary advanced or recurrent endometrial cancer. Dostarlimab also was recently granted Breakthrough Therapy designation for this potential new indication.

Containment 40

Containment Trials Licensing Licensing 40

pharmaphorum

JULY 26, 2021

“We are addressing issues of mistrust and working to reduce systemic issues that deter communities of colour from participating in clinical trials, so that those patients who want to participate, can.”. Some patients, particularly in Black and Brown communities, may not trust medical research due to historical mistreatment.

Clinical Trials 116

Clinical Trials Clinical Trials Trials Production 116

The Pharma Data

AUGUST 15, 2021

The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) regarding the New Drug Application (NDA) for roxadustat for the treatment of anaemia of chronic kidney disease (CKD), in both non-dialysis dependent (NDD) and dialysis-dependent (DD) adult patients. AstraZeneca is working with its partner FibroGen, Inc.

Medicine 52

Medicine Clinical Trials Clinical Trials Production 52

The Pharma Data

APRIL 19, 2022

Kite’s Global CAR T-Cell Therapy Manufacturing Network Increasing Capacity by 50% to Meet Patient Demand for New Cancer Therapies. Food and Drug Administration (FDA) has approved commercial production at the company’s new CAR T-cell therapy manufacturing facility in Frederick, Maryland.

FDA Approval 52

FDA Approval Manufacturing Production Medicine 52

Delveinsight

SEPTEMBER 14, 2021

CEO of SR One, said that the ADARx team focuses on expeditiously translating their insights around RNA biology into novel medicines to benefit patients. The outcomes will also be utilized to transition ADARx’s growing pipeline of research phase products into the clinic, initiating Phase 1 clinical trials for ADARx’s lead program.

RNA 67

RNA Clinical Trials Clinical Trials Drugs 67

Pfizer

MAY 5, 2023

Ready to Respond: Pfizer’s Zithromax® Program & Covid-19 kimkevin Fri, 05/05/2023 - 09:36 Ready to Respond: Pfizer’s Zithromax® Program & Covid-19 Friday, June 05, 2020 - 12:07pm Share Hundreds of colleagues at Pfizer and partner manufacturing sites have come together to respond to the sudden and urgent need for Zithromax® around the world.

Manufacturing 40

Manufacturing Packaging Packaging Medicine 40

Cloudbyz

MAY 5, 2023

Executive Summary Risk-Based Monitoring (RBM) is an approach to clinical trial monitoring that optimizes the use of resources by focusing on trial risks, with the goal of ensuring patient safety, data quality, and regulatory compliance. Methodology of Risk-Based Monitoring 4.1. Benefits of Risk-Based Monitoring 5.1.

Clinical Trials 77

Clinical Trials Clinical Trials Trials Compliance 77

Pfizer

JANUARY 17, 2023

Share. • State-of-the-art biologics drug substance facility will produce Pfizer’s innovative pipeline products and provide additional capacity for in-line medicines. • Expected to more than double the current workforce of new facility by 2025. About Pfizer: Breakthroughs That Change Patients’ Lives.

Manufacturing 85

Manufacturing Containment Development Medicine 85